Verena Ruhlmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Verena Ruhlmann has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Andreas Bockisch
Department of Nuclear Medicine, University Duisburg-Essen, Medical Faculty, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany
5 shared publicationsLale Umutlu
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Duisburg-Essen, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany
4 shared publicationsMichael Forsting
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany
4 shared publicationsMarcus Ruhlmann
Department of Nuclear Medicine, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany
3 shared publicationsAlexander Sascha Brandt
Department of Urology and Paediatric Urology, HELIOS Medical CenterWuppertal, University HospitalWitten/Herdecke, Heusnerstr. 40, 42283, Wuppertal, Germany
2 shared publications- Andreas Bockisch
Klinik für Nuklearmedizin, Universitätsklinikum Essen, Universitätsklinikum der Universität Duisburg-Essen, Essen, Deutschland
2 shared publications
Latest Publications
- 7 May 2020
- Published by Springer Nature
- p. 585-596
PET in Head and Neck Cancer
- Open Access
- 22 December 2017
- Published by Springer Nature in BMC Cancer
- Vol. 17 (1) , 887
Diagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma
The aim of this study was to evaluate the value of 18F–FDG PET/CT (PET/CT) and MRI for local and/or whole-body restaging of adenoid cystic carcinoma of the head and neck (ACC). Thirty-six patients with ACC underwent conventional MRI of the head and neck and a whole-body PET/CT and were analysed with regards to detection of a local tumor recurrence, lymph node or distant metastases. A consensus interpretation of all available imaging data was used as reference standard. Sensitivity, specificity, diagnostic accuracy, positive and negative predictive values were calculated for MRI and PET/CT. The sensitivity of PET/CT and MRI was 96% (89%), specificity 89% (89%), PPV 96% (96%), NPV 89% (73%) and accuracy 94% (89%) for detection of local tumors. Additionally, PET/CT revealed lymph node metastases in one patient and distant metastases in 9/36 patients. In three patients secondary primaries were found. Whole-body PET/CT in addition to MRI of the head and neck improves detection of local tumour and metastastic spread in ACC.
- 22 December 2017
- Published by Springer Nature in BMC Cancer
- Vol. 17 (1) , 887
Open AccessDiagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma
The aim of this study was to evaluate the value of 18F–FDG PET/CT (PET/CT) and MRI for local and/or whole-body restaging of adenoid cystic carcinoma of the head and neck (ACC). Thirty-six patients with ACC underwent conventional MRI of the head and neck and a whole-body PET/CT and were analysed with regards to detection of a local tumor recurrence, lymph node or distant metastases. A consensus interpretation of all available imaging data was used as reference standard. Sensitivity, specificity, diagnostic accuracy, positive and negative predictive values were calculated for MRI and PET/CT. The sensitivity of PET/CT and MRI was 96% (89%), specificity 89% (89%), PPV 96% (96%), NPV 89% (73%) and accuracy 94% (89%) for detection of local tumors. Additionally, PET/CT revealed lymph node metastases in one patient and distant metastases in 9/36 patients. In three patients secondary primaries were found. Whole-body PET/CT in addition to MRI of the head and neck improves detection of local tumour and metastastic spread in ACC.
- Open Access
- 1 March 2017
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 23 (2) , 127-132
Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?
We aimed to investigate the accuracy of 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI) compared with contrast-enhanced 18F-FDG PET/computed tomography (PET/CT) for the characterization of incidental tracer uptake in examinations of the head and neck. A retrospective analysis of 81 oncologic patients who underwent contrast-enhanced 18F-FDG PET/CT and subsequent PET/MRI was performed by two readers for incidental tracer uptake. In a consensus reading, discrepancies were resolved. Each finding was either characterized as most likely benign, most likely malignant, or indeterminate. Using all available clinical information including results from histopathologic sampling and follow-up examinations, an expert reader classified each finding as benign or malignant. McNemar's test was used to compare the performance of both imaging modalities in characterizing incidental tracer uptake. Forty-six lesions were detected by both modalities. On PET/CT, 27 lesions were classified as most likely benign, one as most likely malignant, and 18 as indeterminate; on PET/MRI, 31 lesions were classified as most likely benign, one lesion as most likely malignant, and 14 as indeterminate. Forty-three lesions were benign and one lesion was malignant according to the reference standard. In two lesions, a definite diagnosis was not possible. McNemar's test detected no differences concerning the correct classification of incidental tracer uptake between PET/CT and PET/MRI (P = 0.125). In examinations of the head and neck area, incidental tracer uptake cannot be classified more accurately by PET/MRI than by PET/CT.
- 1 March 2017
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 23 (2) , 127-132
Open AccessIs integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?
We aimed to investigate the accuracy of 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (18F-FDG PET/MRI) compared with contrast-enhanced 18F-FDG PET/computed tomography (PET/CT) for the characterization of incidental tracer uptake in examinations of the head and neck. A retrospective analysis of 81 oncologic patients who underwent contrast-enhanced 18F-FDG PET/CT and subsequent PET/MRI was performed by two readers for incidental tracer uptake. In a consensus reading, discrepancies were resolved. Each finding was either characterized as most likely benign, most likely malignant, or indeterminate. Using all available clinical information including results from histopathologic sampling and follow-up examinations, an expert reader classified each finding as benign or malignant. McNemar's test was used to compare the performance of both imaging modalities in characterizing incidental tracer uptake. Forty-six lesions were detected by both modalities. On PET/CT, 27 lesions were classified as most likely benign, one as most likely malignant, and 18 as indeterminate; on PET/MRI, 31 lesions were classified as most likely benign, one lesion as most likely malignant, and 14 as indeterminate. Forty-three lesions were benign and one lesion was malignant according to the reference standard. In two lesions, a definite diagnosis was not possible. McNemar's test detected no differences concerning the correct classification of incidental tracer uptake between PET/CT and PET/MRI (P = 0.125). In examinations of the head and neck area, incidental tracer uptake cannot be classified more accurately by PET/MRI than by PET/CT.
- 1 November 2016
- Published by Elsevier in European Journal of Radiology
- Vol. 85 (11) , 1941-1947
Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT
- 1 November 2016
- Published by Elsevier in European Journal of Radiology
- Vol. 85 (11) , 1941-1947
Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT
- Open Access
- 7 September 2016
- Published by IntechOpen
124I PET: Pretherapeutic Staging, Detection of Recurrent Thyroid Cancer and Dosimetry
- 7 September 2016
- Published by IntechOpen
Open Access124I PET: Pretherapeutic Staging, Detection of Recurrent Thyroid Cancer and Dosimetry
- Open Access
- 22 March 2016
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 43 (7) , 1395
Erratum to: 18F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease
- 22 March 2016
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 43 (7) , 1395
Open AccessErratum to: 18F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease
- 11 March 2016
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 43 (9) , 1646-1652
18F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease
The aim of this study was to evaluate integrated 18F-FDG PET/MRI as a one-stop diagnostic procedure in the assessment of (active) idiopathic retroperitoneal fibrosis (RPF)
- 11 March 2016
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 43 (9) , 1646-1652
18F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease
The aim of this study was to evaluate integrated 18F-FDG PET/MRI as a one-stop diagnostic procedure in the assessment of (active) idiopathic retroperitoneal fibrosis (RPF)
- 14 December 2015
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 29 (2) , 301-308
Potential influence of Gadolinium contrast on image segmentation in MR-based attenuation correction with Dixon sequences in whole-body 18F-FDG PET/MR
To evaluate the influence of Gadolinium contrast agent on image segmentation in magnetic resonance (MR)-based attenuation correction (AC) with four-segment dual-echo time Dixon-sequences in whole-body [18F]-fluorodeoxyglucose positron emission tomography (PET)/MR imaging, and to analyze the consecutive effect on standardized uptake value (SUV).
- 14 December 2015
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 29 (2) , 301-308
Potential influence of Gadolinium contrast on image segmentation in MR-based attenuation correction with Dixon sequences in whole-body 18F-FDG PET/MR
To evaluate the influence of Gadolinium contrast agent on image segmentation in magnetic resonance (MR)-based attenuation correction (AC) with four-segment dual-echo time Dixon-sequences in whole-body [18F]-fluorodeoxyglucose positron emission tomography (PET)/MR imaging, and to analyze the consecutive effect on standardized uptake value (SUV).
- 21 April 2015
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 187 (S 01) , WSSP304_4
Vergleich eines Ganzkörper-Kurzprotokolls des PET/MRT mit dem PET/CT für die Rezidivdiagnostik von gynäkologischen Tumoren des kleinen Beckens
Zielsetzung: Ziel dieser Studie war die Evaluierung des diagnostischen Potentials eines Ganzkörper-Kurzprotokolls des FDG-PET/MRT im Vergleich zum FDG-PET/CT für die Rezidivdiagnostik von Patientinnen mit gynäkologischen Tumoren. Material und Methodik: An 24 Patientinnen mit dem Verdacht auf ein Rezidiv eines gynäkologischen Tumors des kleinen Beckens wurde im Anschluss an ein klinisch indiziertes PET/CT eine PET/MRT-Untersuchung durchgeführt. Zwei Radiologen beurteilten unabhängig voneinander das akquirierte Bildmaterial und wurden instruiert alle Tumorläsionen zu identifizieren. Für die Beurteilung des PET/MRT wurde ein Ganzkörper-Kurzprotokoll mit folgenden Sequenzen implementiert: 1) eine axiale DWI (EPI)-Sequenz, 2) eine axiale T2w HASTE-Sequenz und 3) eine axiale T1w VIBE-Sequenz nach Kontrastmittelapplikation. Desweiteren wurde in einer qualitativen Analyse, der Tumor-zu-Hintergrund Kontrast im PET und in der DWI anhand einer 4 Punkt-Ordinalskala evaluiert. Ergebnisse: Es wurden insgesamt 104 tumosuspekte Läsionen (Maligne: 81 [78%]; Benigne 23 [22%] detektiert. Die ermittelten Werte für Sensitivität, Spezifität, positiver prädiktiver Wert, negativer prädiktiver Wert und diagnostische Genauigkeit für die Detektion von Tumorläsionen betrugen 82%, 91%, 97%, 58% and 84% für das PET/CT und 85%, 87%, 96%, 63% und 86% für das PET/MRI. Die Unterschiede zwischen den beiden Bildgebungsmodalitäten waren nicht statistisch signifikant (p > 0.05). Zusätzlich konnte kein signifikanter Unterschied für die Abgrenzbarkeit suspekter Läsionen im PET/MRT und im PET/CT nachgewiesen werden (p > 0.05). Schlussfolgerungen: Das Kurzprotokoll des PET/MRT bietet eine dem PET/CT vergleichbar hohe diagnostische Genauigkeit in der Rezidivdiagnostik von gynäkologischen Tumoren des kleinen Beckens. Aufgrund einer nur gering verlängerten Untersuchungsdauer und der Vermeidung ionisierender Strahlung könnte das PET/MRT zukünftig eine vielversprechende Alternative zum PET/CT darstellen.
- 21 April 2015
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 187 (S 01) , WSSP304_4
Vergleich eines Ganzkörper-Kurzprotokolls des PET/MRT mit dem PET/CT für die Rezidivdiagnostik von gynäkologischen Tumoren des kleinen Beckens
Zielsetzung: Ziel dieser Studie war die Evaluierung des diagnostischen Potentials eines Ganzkörper-Kurzprotokolls des FDG-PET/MRT im Vergleich zum FDG-PET/CT für die Rezidivdiagnostik von Patientinnen mit gynäkologischen Tumoren. Material und Methodik: An 24 Patientinnen mit dem Verdacht auf ein Rezidiv eines gynäkologischen Tumors des kleinen Beckens wurde im Anschluss an ein klinisch indiziertes PET/CT eine PET/MRT-Untersuchung durchgeführt. Zwei Radiologen beurteilten unabhängig voneinander das akquirierte Bildmaterial und wurden instruiert alle Tumorläsionen zu identifizieren. Für die Beurteilung des PET/MRT wurde ein Ganzkörper-Kurzprotokoll mit folgenden Sequenzen implementiert: 1) eine axiale DWI (EPI)-Sequenz, 2) eine axiale T2w HASTE-Sequenz und 3) eine axiale T1w VIBE-Sequenz nach Kontrastmittelapplikation. Desweiteren wurde in einer qualitativen Analyse, der Tumor-zu-Hintergrund Kontrast im PET und in der DWI anhand einer 4 Punkt-Ordinalskala evaluiert. Ergebnisse: Es wurden insgesamt 104 tumosuspekte Läsionen (Maligne: 81 [78%]; Benigne 23 [22%] detektiert. Die ermittelten Werte für Sensitivität, Spezifität, positiver prädiktiver Wert, negativer prädiktiver Wert und diagnostische Genauigkeit für die Detektion von Tumorläsionen betrugen 82%, 91%, 97%, 58% and 84% für das PET/CT und 85%, 87%, 96%, 63% und 86% für das PET/MRI. Die Unterschiede zwischen den beiden Bildgebungsmodalitäten waren nicht statistisch signifikant (p > 0.05). Zusätzlich konnte kein signifikanter Unterschied für die Abgrenzbarkeit suspekter Läsionen im PET/MRT und im PET/CT nachgewiesen werden (p > 0.05). Schlussfolgerungen: Das Kurzprotokoll des PET/MRT bietet eine dem PET/CT vergleichbar hohe diagnostische Genauigkeit in der Rezidivdiagnostik von gynäkologischen Tumoren des kleinen Beckens. Aufgrund einer nur gering verlängerten Untersuchungsdauer und der Vermeidung ionisierender Strahlung könnte das PET/MRT zukünftig eine vielversprechende Alternative zum PET/CT darstellen.
- 7 April 2015
- Published by Springer Nature in DNP - Der Neurologe und Psychiater
- Vol. 16 (4) , 40-46
Hybridbildgebung in der Neuroradiologie
- 7 April 2015
- Published by Springer Nature in DNP - Der Neurologe und Psychiater
- Vol. 16 (4) , 40-46
Hybridbildgebung in der Neuroradiologie